Impact of COVID-19 on Economy, Industry and Company :
The emergence of novel coronavirus has affected the global economy, industry dynamics and company’s top line. The entire ecosystem has to suffer the impact of this pandemic disease which would result in significant demand & supply gap, production delay and weak consumer demand of end products across industries. At Bizizz Market Research, our analyst has done extensive research across industries and identify various methodologies which would assist C-Level executive to counter this ongoing threat and make informed business decision.
Kindly contact us to know more details: https://www.bizizzmarketresearch.com/contact
The Glucose Tolerance Test Market Registered USD 41.46 Billion In 2019 And It Is Estimated To Reach More Than US$ 95.40 Billion By 2028, Likely To Grow With A CAGR Of 9.7 % During The Forecast Period.
The glucose tolerance test is used for measuring how well the human body’s cells are able to absorb sugar (glucose) after consumption of specific amount of sugar. This is useful for specialist for diagnose fasting blood sugar level and haemoglobin A1C values as type 1 and type 2 diabetes and also diagnose prediabetes. Perhaps, doctor primarily use a glucose tolerance test for diagnose diabetes during the pregnancy that is called as gestational diabetes.
Intensifying Awareness in Screening For Diabetes Over The Globe Is The Major Contributor For The Success Of Global Glucose Tolerance Test Market
rising innovations in technology and rising awareness in screening for diabetes over the globe is bossing the market by reason of changes in the lifestyle of the public, sedentary lifestyle, and absence of physical exercise is contributing the growth of the glucose tolerance test market, as observed from World Health Organization (WHO) report the global frequency for diabetes among adults have been risen to 8.5% in 2016 that have resulted in 1.6 million estimated deaths worldwide.
The Research Funding In the Diabetes Treatment and Diagnosis Is Also Contributing For the Growth of Global Glucose Tolerance Test Market
The major factor that helps in boosting the glucose tolerance test market is research that are funding in the diabetes treatment and diagnosis. Additionally, various private and government associations in developing countries are contributing for research and diabetes prevention programs that have pioneered new devices for diagnose and treatment that featured into the significant potentials in the market. However, availability of the alternative technology and limited reimbursement and lead for the restraining factor of the global glucose tolerance test market. Moreover, spending on the diabetes care research and development leads to healthcare delivery.
The blood glucose test kit in the product segment is expected to have highest market share and may hit up to US$ 36,164.0 million by end of 2024 owing to easy availability and increasing prevalence of diabetes and also rising demand of home care of diabetes. In terms of indication, the diabetes segment is projected to show highest growth during the forecast period due to increasing prevalence of diabetes. Furthermore, on the basis of end use the diagnostic clinics is expected to have largest market share expected to grow attributable to changing lifestyle owing to the urbanization.
Asia Pacific is anticipated to be the dominant Region
Geographically, Asia pacific regions held significant market share in global markets in 2018 owing to rapidly changing healthcare sectors and arriving new opportunities in the development of glucose tolerance test market.
The Europe market is expected to hold the second highest growth in the glucose tolerance test market owing to the increasing government support in research and development, presence of the geriatric populations, and development in the healthcare infrastructures. Moreover, the North America is projected to have adequate growth in the market share in global glucose tolerance test market with account to the increase in occurrence of the diabetes mellitus, high healthcare expenditure, and advancement in technology.
Most of these players have dominant presence in North America and Europe region. Besides this, as the entry barriers are low owing to low capital investment the market is highly fragmentated. Developing and Under-developed countries are having less awareness concerning depression and availability of Glucose Tolerance Test facilities which results in less availability of screening facilities at these regions.
The companies are focused on strengthening their market foothold by applying organic methods such as strategic merger & acquisition, product launch, and collaborations. For instance, in January 2016 Panasonic Healthcare announced the completion of acquisition with Bayer. The acquisition was for Bayer’s diabetes care business. Furthermore, in September 2016, Abbott received approval from FDA from the production of Freestyle Libre Pro System. This will support the company to achieve recognition in global glucose tolerance test market.
Some of the reputed players operating in this market include Johnson &, Johnson, Dexcom, Inc., Merck, Quest Diagnostics, BAYER, Abbott, ARUP Laboratories, E-Zlab Health Services, Life Extension.
Global Glucose Tolerance Test Market by Product
- Smart Sensors
- Blood Glucose Testing Kit
- Test Strips
Global Glucose Tolerance Test Market by Indication
- Reactive Hypoglycemia
- Gestational Diabetes
- Insulin Resistance
Global Glucose Tolerance Test Market by End Use
- Diagnostic Clinics
Global Glucose Tolerance Test Market by Geography
- North America
- Asia Pacific
- Latin America
- Middle East and Africa